Wells Fargo’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$342K Buy
103,431
+47,979
+87% +$159K ﹤0.01% 4039
2025
Q1
$161K Buy
55,452
+3,930
+8% +$11.4K ﹤0.01% 4394
2024
Q4
$183K Buy
51,522
+18,130
+54% +$64.5K ﹤0.01% 4363
2024
Q3
$166K Buy
33,392
+1,056
+3% +$5.26K ﹤0.01% 4311
2024
Q2
$84.1K Buy
32,336
+8,271
+34% +$21.5K ﹤0.01% 4681
2024
Q1
$103K Buy
24,065
+9,742
+68% +$41.5K ﹤0.01% 4514
2023
Q4
$28.9K Buy
14,323
+48
+0.3% +$97 ﹤0.01% 5065
2023
Q3
$21.8K Buy
14,275
+40
+0.3% +$61 ﹤0.01% 5200
2023
Q2
$23.5K Buy
14,235
+2,854
+25% +$4.71K ﹤0.01% 5390
2023
Q1
$13K Buy
11,381
+4
+0% +$5 ﹤0.01% 5451
2022
Q4
$10.3K Sell
11,377
-9,989
-47% -$9.01K ﹤0.01% 5219
2022
Q3
$25K Sell
21,366
-928
-4% -$1.09K ﹤0.01% 4962
2022
Q2
$14K Buy
22,294
+194
+0.9% +$122 ﹤0.01% 5312
2022
Q1
$58K Buy
22,100
+1,100
+5% +$2.89K ﹤0.01% 5249
2021
Q4
$82K Sell
21,000
-164
-0.8% -$640 ﹤0.01% 5319
2021
Q3
$93K Buy
21,164
+20
+0.1% +$88 ﹤0.01% 5115
2021
Q2
$84K Sell
21,144
-120,248
-85% -$478K ﹤0.01% 5043
2021
Q1
$735K Buy
141,392
+79,751
+129% +$415K ﹤0.01% 4178
2020
Q4
$330K Sell
61,641
-2,271
-4% -$12.2K ﹤0.01% 4708
2020
Q3
$310K Buy
63,912
+18,784
+42% +$91.1K ﹤0.01% 4551
2020
Q2
$219K Buy
45,128
+36,523
+424% +$177K ﹤0.01% 4696
2020
Q1
$19K Buy
8,605
+1,605
+23% +$3.54K ﹤0.01% 5347
2019
Q4
$41K Buy
7,000
+6,000
+600% +$35.1K ﹤0.01% 5308
2019
Q3
$3K Sell
1,000
-15,646
-94% -$46.9K ﹤0.01% 5693
2019
Q2
$70K Sell
16,646
-4,722
-22% -$19.9K ﹤0.01% 5181
2019
Q1
$148K Buy
21,368
+1,595
+8% +$11K ﹤0.01% 4892
2018
Q4
$124K Buy
19,773
+19,034
+2,576% +$119K ﹤0.01% 4963
2018
Q3
$13K Buy
+739
New +$13K ﹤0.01% 5552